← Leaderboards
Cornelia Marja Van Duijn
Duke University
$4,935,431
Attributed
$13,102,308
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.1M · FY2018–22$10M$7.5M$5M$2.5M$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$13,102,308 · 2
By mechanism
U01$9,694,338 · 1
RF1$3,407,970 · 1
Top collaborators
- Rima F Kaddurah-Daouk8 shared
- Gabi Kastenmuller7 shared
Most similar at Duke University
Same institution · by research overlap
- Rima F Kaddurah-Daouk$56,438,861
- Cynthia A Moylan$5,972,949
- Cathrine Hoyo$22,947,053
- Gabi Kastenmuller$6,046,578
- Robert Walker McGarrah$2,798,124
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMetabolomicsCognitionGene ExpressionHeterogeneityMetabolicDatabasesCommunitiesDrug DiscoveryFailureClinical TrialsBiological MarkersInsightLinkGenotypeBrainCohortBrain HealthClassificationDrug DevelopmentBiochemicalDrug TargetingAtlasesMolecular
Grant awards (8)
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,928,443
U01 · FY2022 · AG
Characterizing the AD Metabolome in Brain Tissue Samples of Individuals from Diverse Populations$1,255,605
U01 · FY2022 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,619,858
U01 · FY2021 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,604,844
U01 · FY2020 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$125,041
U01 · FY2020 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,501,317
U01 · FY2019 · AG
Gut Liver Brain Biochemical Axis in Alzheimer's Disease$3,407,970
RF1 · FY2018 · AG
Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD$1,659,230
U01 · FY2018 · AG